• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经历与卵巢癌相关多种症状的女性的医患沟通与感知控制

Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer.

作者信息

Donovan Heidi Scharf, Hartenbach Ellen M, Method Michael W

机构信息

Department of Acute & Tertiary Care, University of Pittsburgh School of Nursing, 336 Victoria Building, 3500 Victoria Street, Pittsburgh, PA 15261, USA.

出版信息

Gynecol Oncol. 2005 Nov;99(2):404-11. doi: 10.1016/j.ygyno.2005.06.062. Epub 2005 Aug 19.

DOI:10.1016/j.ygyno.2005.06.062
PMID:16112174
Abstract

OBJECTIVES

Optimal cancer symptom management requires effective patient-health care provider (HCP) communication. The goals of this study were to 1) describe symptom experiences of women with ovarian cancer, 2) evaluate frequency of patient-HCP communication about symptoms, and 3) evaluate whether communication is associated with patients' confidence in managing symptoms.

METHODS

This was a cross-sectional mailed survey study. The Symptom Experience Survey, containing valid, reliable measures of symptom severity and controllability; symptom communication; and symptom-related coping strategies, was mailed to members of the National Ovarian Cancer Coalition. Descriptive statistics, t tests, correlations, and ANCOVA were used to address study objectives.

RESULTS

This analysis focuses on the 279 respondents who had active disease. The majority of women had recurrent disease (96%) and were on chemotherapy (57%). Women reported a mean of 12 concurrent symptoms. Fatigue, bowel disturbances, and peripheral neuropathies were the most severe and most noticed symptoms. Only 61% of women had discussed their most noticed symptom with an HCP in the past month, and only 50% of women reported that they had received symptom management recommendations. Women reported low levels of perceived control over symptoms (M = 1.97 on a 0-4 scale). There was a significant interaction effect for symptom discussions and management recommendations on perceived control. Women who had never received recommendations had low perceived control whether or not they had discussed their symptom with an HCP in the past month. For women who had received recommendations, those who had discussed their symptom with an HCP in the past month had higher perceived control compared to those who had not discussed their symptom.

CONCLUSIONS

Women with ovarian cancer experience multiple symptoms, but many do not discuss symptoms with their HCPs and fewer report receiving symptom management recommendations. Women would benefit from more active symptom assessment and discussion of management strategies by HCPs.

摘要

目的

优化癌症症状管理需要患者与医护人员(HCP)进行有效的沟通。本研究的目的是:1)描述卵巢癌女性的症状体验;2)评估患者与医护人员就症状进行沟通的频率;3)评估沟通是否与患者管理症状的信心相关。

方法

这是一项横断面邮寄调查研究。将包含症状严重程度和可控性的有效、可靠测量指标、症状沟通以及症状相关应对策略的症状体验调查问卷邮寄给国家卵巢癌联盟的成员。使用描述性统计、t检验、相关性分析和协方差分析来实现研究目标。

结果

本分析聚焦于279名患有活动性疾病的受访者。大多数女性患有复发性疾病(96%)且正在接受化疗(57%)。女性报告平均同时出现12种症状。疲劳、肠道功能紊乱和周围神经病变是最严重且最常被注意到的症状。在过去一个月中,只有61%的女性与医护人员讨论过她们最常注意到的症状,只有50%的女性报告称她们收到了症状管理建议。女性报告对症状的感知控制水平较低(在0至4的量表上,M = 1.97)。症状讨论和管理建议对感知控制有显著的交互作用。从未收到建议的女性,无论过去一个月是否与医护人员讨论过症状,其感知控制水平都较低。对于收到建议的女性,过去一个月与医护人员讨论过症状的女性比未讨论过症状的女性有更高的感知控制水平。

结论

卵巢癌女性经历多种症状,但许多人未与医护人员讨论症状,更少有人报告收到症状管理建议。医护人员更积极地进行症状评估并讨论管理策略将使女性受益。

相似文献

1
Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer.经历与卵巢癌相关多种症状的女性的医患沟通与感知控制
Gynecol Oncol. 2005 Nov;99(2):404-11. doi: 10.1016/j.ygyno.2005.06.062. Epub 2005 Aug 19.
2
Canadian women's perspectives on ovarian cancer.加拿大女性对卵巢癌的看法。
Cancer Prev Control. 1999 Feb;3(1):52-60.
3
Representations of fatigue in women receiving chemotherapy for gynecologic cancers.接受妇科癌症化疗的女性疲劳状况
Oncol Nurs Forum. 2005 Jan 19;32(1):113-6. doi: 10.1188/05.ONF.113-116.
4
Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy.
Oncol Nurs Forum. 2010 Sep;37(5):596-603. doi: 10.1188/10.ONF.596-603.
5
A study of symptoms described by ovarian cancer survivors.卵巢癌幸存者症状描述研究。
Gynecol Oncol. 2012 Apr;125(1):59-64. doi: 10.1016/j.ygyno.2011.12.421. Epub 2011 Dec 9.
6
Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.癌症及与治疗相关的症状与卵巢癌女性的行动不便有关:一项横断面研究。
Gynecol Oncol. 2016 Dec;143(3):578-583. doi: 10.1016/j.ygyno.2016.09.013. Epub 2016 Sep 18.
7
OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.OVQUEST-卵巢癌诊断和治疗后的生活-卵巢癌幸存者症状和担忧的国际调查。
Gynecol Oncol. 2019 Oct;155(1):126-134. doi: 10.1016/j.ygyno.2019.08.009. Epub 2019 Aug 13.
8
Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?复发性卵巢癌女性的症状管理:患者和临床医生对哪些症状最为重要是否达成共识?
Gynecol Oncol. 2016 Nov;143(2):367-370. doi: 10.1016/j.ygyno.2016.08.235. Epub 2016 Aug 13.
9
Creating Individualized Symptom Management Goals and Strategies for Cancer-Related Fatigue for Patients With Recurrent Ovarian Cancer.为复发性卵巢癌患者制定针对癌症相关疲劳的个性化症状管理目标和策略。
Cancer Nurs. 2017 Jul/Aug;40(4):305-313. doi: 10.1097/NCC.0000000000000407.
10
Linkages among empathic behaviors, physical symptoms, and psychological distress in patients with ovarian cancer: a pilot study.
Oncol Nurs Forum. 2008 Sep;35(5):808-14. doi: 10.1188/08.ONF.808-814.

引用本文的文献

1
Estimating diagnostic delay in patients with pituitary adenomas in Sweden: a cross-sectional study.瑞典垂体腺瘤患者诊断延迟的估计:一项横断面研究。
BMJ Open. 2025 Jun 23;15(6):e097804. doi: 10.1136/bmjopen-2024-097804.
2
Challenges of Ovarian Cancer Patient and Caregiver Online Health Information Seeking.卵巢癌患者及护理人员在线寻求健康信息的挑战
Proc Assoc Inf Sci Technol. 2021;58(1):688-690. doi: 10.1002/pra2.530. Epub 2021 Oct 13.
3
Barriers to discussing fatigue in oncological care: a comparative study of patient perspectives after two decades.
肿瘤护理中讨论疲劳问题的障碍:二十年后患者观点的比较研究
Support Care Cancer. 2025 Apr 2;33(4):341. doi: 10.1007/s00520-025-09390-0.
4
Symptom clusters and network analysis in patients with gynecologic cancer undergoing chemotherapy: A cross-sectional study.妇科癌症化疗患者的症状群与网络分析:一项横断面研究。
Asia Pac J Oncol Nurs. 2024 Oct 26;11(12):100612. doi: 10.1016/j.apjon.2024.100612. eCollection 2024 Dec.
5
Identifying symptom cluster in cancer patients undergoing chemotherapy-in Vietnam: A cross-sectional study.癌症化疗患者症状群的识别:一项横断面研究。
PLoS One. 2024 Sep 20;19(9):e0307725. doi: 10.1371/journal.pone.0307725. eCollection 2024.
6
Women with ovarian cancer's information seeking and avoidance behaviors: an interview study.卵巢癌女性的信息寻求与回避行为:一项访谈研究。
JAMIA Open. 2024 Feb 21;7(1):ooae011. doi: 10.1093/jamiaopen/ooae011. eCollection 2024 Apr.
7
Symptom clusters among breast cancer patients in relation to chemotherapy cycles: a longitudinal study.乳腺癌患者化疗周期相关症状群:一项纵向研究。
Support Care Cancer. 2023 Sep 12;31(10):573. doi: 10.1007/s00520-023-08038-1.
8
Mediational roles of stress-coping factors in the relationship between patient-perceived communication quality and physical functioning: racial difference between Chinese and Non-Hispanic White American breast cancer survivors.压力应对因素在患者感知的沟通质量与身体功能之间关系中的中介作用:中国和非西班牙裔白种美国乳腺癌幸存者之间的种族差异。
Qual Life Res. 2024 Jan;33(1):253-265. doi: 10.1007/s11136-023-03501-2. Epub 2023 Aug 17.
9
A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy.一种多方法结合的方式来选择 PRO-CTCAE 症状,以用于接受化疗的子宫内膜癌或卵巢癌女性的患者报告结局。
J Patient Rep Outcomes. 2023 Jul 18;7(1):72. doi: 10.1186/s41687-023-00611-w.
10
Effect of personalized care based on OPT model on perceived control and quality of life among patients with breast cancer.基于 OPT 模型的个性化护理对乳腺癌患者感知控制和生活质量的影响。
Front Public Health. 2023 Apr 17;11:1149558. doi: 10.3389/fpubh.2023.1149558. eCollection 2023.